• In tandem with Migami, initiated construction of manufacturing facility in South Korea intended to serve Southeast Asian markets and dietary supplement markets within the United States
  • Committed to extensive distribution of Bi-Layer products within burgeoning Korean market
  • As of 2007, total assets exceeded USD 13 billion
 
  Manufacturing
Korean Tobacco & Ginseng / Yungjin Pharmaceutical Company, Ltd.
BioZone
SMI
InnoZen